Drug addiction in hepatitis C patients leads to a lower quality of life

Nordic Journal of Psychiatry

Volumn 60, Issue 2, 2006, Pages 157-161

  Gjeruldsen, Susanne ^a   Loge, Jon Håvard ^b   Myrvang, Bjoørn ^a   Opjordsmoen, Stein ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Chronic hepatitis C; Health related quality of life; Psychiatric disorders; Short Form 36; Substance use disorders

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; FEMALE; HEALTH STATUS; HEPATITIS C; HUMAN; INTRAVENOUS DRUG ABUSE; MALE; MARRIAGE; NORWAY; QUALITY OF LIFE; SCORING SYSTEM; SHORT FORM 36;

EID: 33646111913     PISSN: 08039488     EISSN: 15024725     Source Type: Journal    
DOI: 10.1080/08039480600583639     Document Type: Article

References (21)

1. Skretting A. Patterns on the European drug scene. An exploration of differences. Waal H, editor.Oslo: National Institute for Alcohol and Drug Research; 1998. p. 142-6.
2. Kielland, KB and Siebke, JC. (1991) Hepatitis A-, B- and C-markers among Norwegian drug addicts in the period 1975-89 Tidsskr Nor Laegeforen, 111, pp. 821-4.
3. Gjeruldsen, S and Abdelnoor, M and Opjordsmoen, S and Myrvang, B. (2001) Death rates and causes of death in cohorts of serum hepatitis patients followed up for more than 20 years Epidemiol Infect, 126, pp. 89-96.
4. Benson, G. (1985) Course and outcome of drug abuse and medical and social conditions in selected young drug abusers Acta Psychiatr Scand, 71, pp. 48-66.
5. Hammersley, R and Lavelle, TL and Forsyth, AJ. (1992) Adolescent drug use, health and personality Drug Alcohol Depend, 31, pp. 91-99.
6. Holmberg, MB. (1985) Longitudinal studies of drug abuse in a fifteen-year-old population. 4. Chronic drug abusers Acta Psychiatr Scand, 71, pp. 201-3.
7. Kokkevi, A and Stefanis, C. (1995) Drug abuse and psychiatric comorbidity Compr Psychiatry, 36, pp. 329-37.
8. Gjeruldsen, S and Myrvang, B and Opjordsmoen, S. (2003) A 25-year follow-up study of drug addicts hospitalised for acute hepatitis. Present and past morbidity Eur Addict Res, 9, pp. 80-6.
9. Carithers, RL, Jr and Sugano, D and Bayliss, M. (1996) Health assessment for chronic HCV infection: Results of quality of life Digest Dis Sci, 41(12 Suppl), pp. 75S-80S.
10. Ware, JEJ and Bayliss, MS and Mannocchia, M and Davis, GL. (1999) Health-related quality of life in chronic hepatitis C: Impact of disease and treatment response. The Interventional Therapy Group Hepatology, 30, pp. 550-5.
11. Loge, JH and Kaasa, S. (1998) Short Form 36 (SF-36) health survey: normative data from the general Norwegian population Scand J Soc Med, 26, pp. 250-8.
12. Gjeruldsen, S and Myrvang, B and Opjordsmoen, S. (2003) Risk factors for drug addiction and its outcome. A follow-up study over 25 years Nord J Psychiatry, 57, pp. 373-6.
13. Ware, JE, Jr and Gandek, B. (1998) Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project J Clin Epidemiol, 51, pp. 903-12.
14. Ware, JEJ.(1997) Scoring the SF-36 Health Survey. In SF-36 Health Survey. Manual & interpretation guide. (pp. 1-22). Boston MA: Medical Outcomes Trust.
15. Loge, JH and Kaasa, S and Hjermstad, MJ and Kvien, TK. (1998) Translation and performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. I. Data quality, scaling assumptions, reliability, and construct validity J Clin Epidemiol, 51, pp. 1069-76.
16. Ware, JE, Jr and Gandek, B. (1998) Methods for testing data quality, scaling assumptions, and reliability: The IQOLA Project approach. International Quality of Life Assessment J Clin Epidemiol, 51, pp. 945-52.
17. Altman DG, editor. In:PRactical statistics for medical research. London: Chapman and Hall; 1991. p. 194-244.
18. Foster, GR and Goldin, RD and Thomas, HC. (1998) Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis Hepatology, 27, pp. 209-12.
19. Rodger, AJ and Jolley, D and Thompson, SC and Lanigan, A and Crofts, N. (1999) The impact of diagnosis of hepatitis C virus on quality of life Hepatology, 30, pp. 1299-301.
20. Wessely, S and Pariante, C. (2002) Fatigue, depression and chronic hepatitis C infection Psychol Med, 32, pp. 1-10.
21. Bonkovsky, HL and Woolley, JM. (1999) Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group Hepatology, 29, pp. 264-70.